These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 15102019

  • 1. SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosis.
    Visconte C, Sainte-Marie M, Lorrain J, Millet L, O'Connor SE, Schaeffer P, Herbert JM.
    J Thromb Haemost; 2004 Apr; 2(4):629-36. PubMed ID: 15102019
    [Abstract] [Full Text] [Related]

  • 2. Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor.
    Lorrain J, Millet L, Lechaire I, Lochot S, Ferrari P, Visconte C, Sainte-Marie M, Lunven C, Berry CN, Schaeffer P, Herbert JM, O'Connor SE.
    J Pharmacol Exp Ther; 2003 Feb; 304(2):567-74. PubMed ID: 12538808
    [Abstract] [Full Text] [Related]

  • 3. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR, Wu Z, Pauwels P, Lijnen HR, Collen D.
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [Abstract] [Full Text] [Related]

  • 4. Time course of thrombolysis induced by intravenous bolus or infusion of tissue plasminogen activator in a rabbit jugular vein thrombosis model.
    Clozel JP, Tschopp T, Luedin E, Holvoet P.
    Circulation; 1989 Jan; 79(1):125-33. PubMed ID: 2491972
    [Abstract] [Full Text] [Related]

  • 5. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G, Pascucci C, Nenci GG, Mele A, Bürgi R, Heim J.
    Thromb Haemost; 1993 Aug 02; 70(2):294-300. PubMed ID: 8236138
    [Abstract] [Full Text] [Related]

  • 6. Comparison of intravenous bolus injection or continuous infusion of recombinant single chain urokinase-type plasminogen activator (saruplase) for thrombolysis. A canine model of combined coronary arterial and femoral venous thrombosis.
    Rapold HJ, Wu ZM, Stassen T, Van de Werf F, Collen D.
    Blood; 1990 Oct 15; 76(8):1558-63. PubMed ID: 2119830
    [Abstract] [Full Text] [Related]

  • 7. An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.
    Nagashima M, Werner M, Wang M, Zhao L, Light DR, Pagila R, Morser J, Verhallen P.
    Thromb Res; 2000 May 15; 98(4):333-42. PubMed ID: 10822080
    [Abstract] [Full Text] [Related]

  • 8. A novel platelet-rich arterial thrombosis model in rabbits. Simple, reproducible, and dynamic real-time measurement by using double-opposing inverted-sutures model.
    Shieh SJ, Chiu HY, Shi GY, Wu CM, Wang JC, Chen CH, Wu HL.
    Thromb Res; 2001 Sep 01; 103(5):363-76. PubMed ID: 11553369
    [Abstract] [Full Text] [Related]

  • 9. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D, Stassen JM, Verstraete M.
    J Clin Invest; 1983 Feb 01; 71(2):368-76. PubMed ID: 6681615
    [Abstract] [Full Text] [Related]

  • 10. Fibrinolytic agents for peripheral arterial occlusion.
    Robertson I, Kessel DO, Berridge DC.
    Cochrane Database Syst Rev; 2013 Dec 19; 2013(12):CD001099. PubMed ID: 24357258
    [Abstract] [Full Text] [Related]

  • 11. Fibrinolytic agents for peripheral arterial occlusion.
    Robertson I, Kessel DO, Berridge DC.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD001099. PubMed ID: 20238313
    [Abstract] [Full Text] [Related]

  • 12. Effects of therapeutic doses of heparin on thrombolysis with tissue-type plasminogen activator in rabbits.
    Agnelli G, Pascucci C, Cosmi B, Nenci GG.
    Blood; 1990 Nov 15; 76(10):2030-6. PubMed ID: 2122919
    [Abstract] [Full Text] [Related]

  • 13. In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activator.
    Jang IK, Gold HK, Leinbach RC, Fallon JT, Collen D.
    Circ Res; 1990 Dec 15; 67(6):1552-61. PubMed ID: 2123135
    [Abstract] [Full Text] [Related]

  • 14. Transcatheter thrombolysis with high-dose bolus tissue plasminogen activator in iatrogenic arterial occlusion after femoral arterial catheterization.
    Tsetis DK, Kochiadakis GE, Hatzidakis AA, Skalidis EI, Chryssou EG, Tritou IN, Vardas PE, Gourtsoyiannis NC.
    Cardiovasc Intervent Radiol; 2002 Dec 15; 25(1):36-41. PubMed ID: 11907772
    [Abstract] [Full Text] [Related]

  • 15. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
    Collen D, Lu HR, Lijnen HR, Nelles L, Stassen JM.
    Circulation; 1991 Sep 15; 84(3):1216-34. PubMed ID: 1909220
    [Abstract] [Full Text] [Related]

  • 16. Ultrasound-assisted thrombolysis with streptokinase improves thrombus resolution with minimal distal embolisation.
    Adzerikho I, Shantsila E, Minchenya V, Kulak A.
    J Thromb Thrombolysis; 2013 Oct 15; 36(3):263-70. PubMed ID: 23180283
    [Abstract] [Full Text] [Related]

  • 17. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B, Fareed J.
    Thromb Haemost; 1996 Oct 15; 76(4):615-20. PubMed ID: 8903005
    [Abstract] [Full Text] [Related]

  • 18. Potentiating effect of clopidogrel and SR 46349, a novel 5-HT2 antagonist, on streptokinase-induced thrombolysis in the rabbit.
    Herbert JM, Bernat A, Sainte-Marie M, Dol F, Rinaldi M.
    Thromb Haemost; 1993 Mar 01; 69(3):268-71. PubMed ID: 8470050
    [Abstract] [Full Text] [Related]

  • 19. Low molecular weight heparin (Fragmin) prevents early reocclusion following femoral artery thrombolysis with rt-PA in rabbits.
    Kornowski R, Glikson M, Hasdai D, Chernine A, Ohad D, Battler A.
    Eur Heart J; 1994 Apr 01; 15(4):541-6. PubMed ID: 8070483
    [Abstract] [Full Text] [Related]

  • 20. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
    Ueshima S, Matsuno H, Hayashi M, Horibuchi K, Okada K, Fukao H, Uematsu T, Matsuo O.
    Thromb Haemost; 2002 Jun 01; 87(6):1069-74. PubMed ID: 12083488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.